Table of contents


cover image
Top

In This Issue

In this issue pv

doi:10.1038/nchembio0208-v


Top

Editorial

Forging synergies in drug discovery p83

doi:10.1038/nchembio0208-83

The pharmaceutical industry faces major challenges in delivering the next generation of therapeutic agents. The shared interests of pharmaceutical researchers and chemical biologists provide impetus for new drug discovery innovations.


Top

News and Views

Copper shares a piece of the pi pp85 - 86

Katherine J Franz

doi:10.1038/nchembio0208-85

Recent crystal structures of a bacterial copper tolerance protein reveal an intriguing copper binding site that includes tryptophan. Its close proximity coupled with spectroscopic data suggests an unusual cation-pi interaction between Cu(I) and the aromatic ring of tryptophan.

See also: Brief Communication by Xue et al.


Small molecule versus DNA repair nanomachine pp86 - 88

James T Stivers

doi:10.1038/nchembio0208-86

The MRN protein megacomplex mediates repair of double-stranded DNA breaks (DSBs) by tethering together broken ends of chromosomes and signaling a cascade of events required for DNA repair. The first small-molecule inhibitor that disrupts MRN function provides a valuable new tool for functional studies of DSB repair in cells.

See also: Article by Dupré et al.


Worming our way to the fountain of youth pp88 - 89

Peter John Roy

doi:10.1038/nchembio0208-88

Extending the time animals spend in the vigorous phase of their lives would have enormous economical and social consequences. A new study reveals that antidepressants commonly used in humans can significantly prolong the life of nematodes by antagonizing conserved G protein–coupled receptors.


Unexpected tails of a Ca2+ sensor pp90 - 91

Lee P Haynes & Robert D Burgoyne

doi:10.1038/nchembio0208-90

Myristoylation is an important post-translational modification that targets many signaling proteins to membranes. Now the crystal structure of calcium-bound myristoylated GCAP-1 demonstrates a new structural role for protein myristoylation.


Losing inhibition with ketamine pp91 - 93

Jeremy Seamans

doi:10.1038/nchembio0208-91

Schizophrenia is thought to involve a dysfunction of glutamatergic and GABAergic signaling in the prefrontal cortex, but how these systems interact in the disease has been unclear. Now ketamine, a glutamatergic NMDA receptor antagonist, may provide a mechanism that could link these pathways.


Research highlights p95

doi:10.1038/nchembio0208-95


Top

Brief Communications

Cu(I) recognition via cation-pi and methionine interactions in CusF pp107 - 109

Yi Xue, Anna V Davis, Gurusamy Balakrishnan, Jay P Stasser, Benjamin M Staehlin, Pamela Focia, Thomas G Spiro, James E Penner-Hahn & Thomas V O'Halloran

doi:10.1038/nchembio.2007.57

no alt info

See also: News and Views by Franz



Top

Articles

Glyoxylate carboligase lacks the canonical active site glutamate of thiamine-dependent enzymes pp113 - 118

Alexander Kaplun, Elad Binshtein, Maria Vyazmensky, Andrea Steinmetz, Ze'ev Barak, David M Chipman, Kai Tittmann & Boaz Shaanan

doi:10.1038/nchembio.62

no alt info

A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex pp119 - 125

Aude Dupré, Louise Boyer-Chatenet, Rose M Sattler, Ami P Modi, Ji-Hoon Lee, Matthew L Nicolette, Levy Kopelovich, Maria Jasin, Richard Baer, Tanya T Paull & Jean Gautier

doi:10.1038/nchembio.63

no alt info

See also: News and Views by Stivers


Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling pp126 - 131

Jean-Pierre Vilardaga, Viacheslav O Nikolaev, Kristina Lorenz, Sébastien Ferrandon, Zhenjie Zhuang & Martin J Lohse

doi:10.1038/nchembio.64

no alt info


Top

Extra navigation

Subscribe to Nature Chemical Biology

Subscribe

Open Innovation Challenges

naturejobs